Pacer Advisors, Inc. Enanta Pharmaceuticals Inc Transaction History

Pacer Advisors, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 21, 2021	SELL	$43.76 - $53.11 $34,920 - $42,381	-798 Closed	0 $0
Q1 2021 Apr 05, 2021	SELL	$41.69 - $54.95 $15,258 - $20,111	-366 Reduced 31.44%	798 $39,000
Q4 2020 Jan 20, 2021	BUY	$41.16 - $47.47 $10,783 - $12,437	262 Added 29.05%	1,164 $49,000
Q3 2020 Oct 19, 2020	BUY	$43.36 - $53.53 $39,110 - $48,284	902 New	902 $41,000
Q4 2019 Feb 10, 2020	SELL	$57.95 - $66.61 $299,601 - $344,373	-5,170 Closed	0 $0
Q3 2019 Oct 10, 2019	BUY	$60.08 - $88.17 $74,138 - $108,801	1,234 Added 31.35%	5,170 $311,000
Q2 2019 Aug 12, 2019	BUY	$81.3 - $97.35 $319,996 - $383,169	3,936 New	3,936 $332,000
Q4 2018 Feb 13, 2019	SELL	$65.41 - $84.65 $176,149 - $227,962	-2,693 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$85.46 - $126.37 $230,143 - $340,314	2,693 New	2,693 $230,000
Q1 2018 May 14, 2018	SELL	$57.91 - $92.15 $26,059 - $41,467	-450 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$45.65 - $59.37 $20,542 - $26,716	450	450 $26,000

108

19.7M

9.7K

12.4K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $126M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.